MyFinsight
Home
Blog
About
Proceeds from
convertible debt
$243,750K
Proceeds from sale of
marketable securities
$73,939K
(-45.92%↓ Y/Y)
Proceeds from exercises
of options
$3,501K
(359.45%↑ Y/Y)
Proceeds from issuance of
common stock under espp
-$1,247K
(-133.96%↓ Y/Y)
Net cash provided by
financing activities
$170,529K
(-11.84%↓ Y/Y)
Net cash (used in)
provided by investing...
$5,991K
(-89.08%↓ Y/Y)
Canceled cashflow
$78,833K
Canceled cashflow
$67,948K
Net (decrease)
increase in cash and cash...
$133,213K
(-33.39%↓ Y/Y)
Canceled cashflow
$43,307K
Payments on borrowings
and amendment fee...
$58,687K
(35253.61%↑ Y/Y)
Payments on capped call
transactions
$17,135K
Payments on revenue
interest financing...
$1,882K
Payments on debt issuance
costs
$1,129K
(-82.91%↓ Y/Y)
Accrued expenses
$13,772K
(12892.45%↑ Y/Y)
Stock-based compensation
$10,460K
(-13.06%↓ Y/Y)
Loss on debt
extinguishment
-$9,472K
Non-cash interest on
revenue interest...
-$5,097K
(-1816.17%↓ Y/Y)
Prepaid expenses and
other current assets
-$2,111K
(-1236.08%↓ Y/Y)
Depreciation and
amortization
$536K
(50.56%↑ Y/Y)
Amortization of debt issuance
costs
$350K
(1844.44%↑ Y/Y)
Purchases of marketable
securities
$67,694K
(-17.11%↓ Y/Y)
Purchases of property and
equipment
$254K
(40.33%↑ Y/Y)
Net cash used in
operating activities
-$42,969K
(10.81%↑ Y/Y)
Effect of foreign
exchange rate changes on...
-$338K
(-164.06%↓ Y/Y)
Canceled cashflow
$41,798K
Net income (loss)
-$62,840K
(-6.50%↓ Y/Y)
Accounts payable
-$9,846K
(-182.86%↓ Y/Y)
Accounts receivable
$5,103K
(123.42%↑ Y/Y)
Inventory
$4,057K
(654.09%↑ Y/Y)
Contract liabilities
$1,311K
(-40.38%↓ Y/Y)
Amortization of premium and
discounts on marketable...
$711K
(-46.74%↓ Y/Y)
Interest receivable on
marketable securities
$627K
(158.65%↑ Y/Y)
Unrealized foreign
currency transaction...
$208K
(-54.08%↓ Y/Y)
Non-cash lease expense
-$54K
(-131.58%↓ Y/Y)
Net loss on disposal
of fixed assets
$31K
(191.18%↑ Y/Y)
Back
Back
Cash Flow
cropped-static1-svg
source: myfinsight.com
Nuvation Bio Inc. (NUVB)
cropped-static1-svg
Nuvation Bio Inc. (NUVB)